Quality
We put our customers first. By offering user-friendly immunological assays, proficient technical service, and efficient delivery, we aim to always be of service.
Native protein precision
At Mabtech, we set the gold standard in monoclonal antibody (mAb) development by focusing on targeting native proteins. Our mAbs are selected to recognize proteins in their natural, correctly folded, and post-translationally modified state, ensuring unparalleled accuracy in research settings.
We go beyond individual antibody testing, particularly in sandwich assays, by meticulously pairing mAbs that bind different epitopes of the native protein. This comprehensive approach in testing both coating and detection mAbs guarantees optimal results in ELISA, ELISpot, and FluoroSpot assays.
Our rigorous protocols reflect our commitment to providing high-quality, reliable mAbs, ensuring what works in our labs will work seamlessly in yours. Read more about why targeting the native protein matters here.
We are ISO-certified
We listen carefully to the needs of our customers and respond accordingly in order to build mutually fruitful relations. The aim to satisfy customer needs involves everyone at Mabtech and affects all customer communication. We are proud of continuously receiving numerous positive feedbacks and many returning customers.
Mabtech AB has chosen to comply with the international standards ISO 9001 and ISO 13485, for the establishment, maintenance and development of its quality management system. The compliance is audited annually by external audits and the certificates have been maintained without interruption since 2006 when Mabtech AB first aimed for certification.
Sustainability equals quality
At Mabtech, we prioritize continuous learning and growth, even if it means unlearning established practices.
From the way we source materials to our product development and waste management, we are committed to creating solutions that support a healthier planet. Our goal is to deliver life-changing science while preserving resources and minimizing impact, ensuring a sustainable future for generations to come.
Read more on our approach to sustainability here.
Compliant instruments
The EU and the US (FDA) have established guidelines for the life sciences industry, known as Annex 11 and CFR21 part 11, respectively. These guidelines outline the use of computerized systems in clinical investigations and specify that the quality of source data obtained through these systems must match that of traditional paper records.
The software Mabtech Opal™ used for operation of Mabtech EYRA™ has been developed to comply with CFR21 part 11.
Likewise, the software Mabtech Apex™ used for operations of Mabtech IRIS™ and Mabtech ASTOR™ has been designed to comply with the following guidelines § 11.10 Controls for closed systems of CFR21:
